Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.126x

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a cash flow conversion efficiency ratio of 0.126x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL33.37 Million ≈ $747.36K USD) by net assets (TL263.88 Million ≈ $5.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Oncosem Onkolojik Sistemler Sanayi ve Ti for a breakdown of total debt and financial obligations.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sebo Manufacturing Engineering & Construction Corp KQ:011560	-0.008x
RAINBOW RARE EARTHS LTD F:RR1	N/A
Douglas Elliman Inc NYSE:DOUG	-0.078x
Gabelli MultiMedia Mutual Fund NYSE:GGT	N/A
BCB Bancorp Inc NASDAQ:BCBP	0.029x
ANDHRA PAPER LIMITED NSE:ANDHRAPAP	0.033x
Annehem Fastigheter AB ST:ANNE-B	0.011x
CF Bankshares Inc NASDAQ:CFBK	0.014x

Annual Cash Flow Conversion Efficiency for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. For the full company profile with market capitalisation and key ratios, see Oncosem Onkolojik Sistemler Sanayi ve Ti market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	TL231.70 Million ≈ $5.19 Million	TL-38.10 Million ≈ $-853.43K	-0.164x	-169.94%
2022-12-31	TL224.08 Million ≈ $5.02 Million	TL52.69 Million ≈ $1.18 Million	0.235x	-64.14%
2021-12-31	TL78.80 Million ≈ $1.76 Million	TL51.68 Million ≈ $1.16 Million	0.656x	+156.87%
2020-12-31	TL76.02 Million ≈ $1.70 Million	TL19.41 Million ≈ $434.68K	0.255x	--

About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices

Market Cap

$146.50 Million

TL6.54 Billion TRY

Market Cap Rank

#17742 Global

#245 in Turkey

Share Price

TL274.25

Change (1 day)

+0.83%

52-Week Range

TL76.85 - TL342.00

All Time High

TL342.00